Loestrin Buyers' $1M Lupin Deal Gets Initial Approval
Lupin Pharmaceuticals Inc. and a group of end payors won preliminary approval of a $1 million settlement to end their portion of multidistrict litigation accusing the drugmaker and two other pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article